AMGEN INC — Director's Dealing 2012

Jul 31, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2012-07-30

Reporting Person: REASON J PAUL (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-07-30	Common Stock	M	5000	$74.89	Acquired	23139	Direct
2012-07-30	Common Stock	M	5000	$71.64	Acquired	28139	Direct
2012-07-30	Common Stock	F	4462	$83.92	Disposed	23677	Direct
2012-07-30	Common Stock	F	4269	$83.92	Disposed	19408	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-07-30	Nqso (Right to Buy)	$74.89	M	5000	Disposed	2013-03-15	Common Stock (5000)	Direct
2012-07-30	Nqso (Right to Buy)	$71.64	M	5000	Disposed	2022-04-27	Common Stock (5000)	Direct

Footnotes

F1: These shares include 124 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's unvested, and vested but deferred, Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.